Analysts at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued to clients and investors on Saturday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright increased their price objective on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.
SenesTech Stock Down 8.2 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- What to Know About Investing in Penny Stocks
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What is diluted earnings per share (Diluted EPS)?
- 5 Best Gold ETFs for March to Curb Recession Fears
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.